NOBIVAC® Edge DAPPv+L4

NOBIVAC EDGE^® DAPPv+L₄

Smaller, 0.5-mL dose proven effective against several common viruses and enhanced quality in leptospirosis protection by using the VacciPure™ filtration process.

Product Description

NOBIVAC EDGE^® DAPPv+L₄ helps keep dogs healthy in a 0.5 mL vaccine

Canine Distemper Virus, Canine Adenovirus Type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses), Leptospira Canicola- Grippotyphosa-Icterohaemorrhagiae-Pomona (inactivated bacterin).

Effective against all known strains of canine parvovirus (CPV), including CPV-2c^2,3
The only leptospirosis vaccine proven effective against mortality and urinary shedding.
Prevented mortality caused by 4 virulent Leptospira serovars¹
Effective against adenovirus type 1 that causes hepatitis in dogs
Proven effective against commonly spread canine viruses, distemper, adenovirus type 1 (hepatitis), parainfluenza and parvovirus, in 1 formula

PRODUCT LABEL

Overview

Administration

Alternate

Disease Information

Resources

Indications:

Shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus, canine parvovirus, Leptospira canicola, L.icterohaemorrhagiae, L.pomona and L.grippotyphosa.

Also shown to be effective against mortality and leptospiruria (shedding of Leptospira in the urine) caused by L. canicola, L. icterohaemorrhagiae, L.pomona and L.grippotyphosa.